prostatecancernewstoday.com...
Is anyone familiar with irofluven, which comes from jack o' lanern mushrooms?
This news today sparked my curiosity, so I did a couple quick searches on irofluven and discovered it isn't new, and was even fast tracked over 15 years ago:
Lots of info, so I'm hoping someone here who can decipher all this medical terminology may find irofuven to be very promising:
duckduckgo.com/?q=%2Biroful...
oncologyventure.com/pipelin...
"Irofulven has been evaluated in 19 clinical trials, predominantly in refractory prostate and ovarian cancer patients and all conducted without DRP-guided patient selection. Results were positive, including a 10% response rate in patients with prostate cancer previously treated with docetaxel and 13% in ovarian cancer patients relapsing between 6 and 12 months after standard treatment with carboplatin and paclitaxel, but were not deemed sufficient for regulatory approval by the previous owner of the drug.
*****The ongoing and planned studies using the Irofulven DRP are expected to significantly improve response rates seen in prior studies.*****"